SoFi CEO enters prepaid forward contract on 1.5 million shares
Investing.com - Nurix reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Nurix announced earnings per share of $-0.90 on revenue of $10.79M. Analysts polled by Investing.com EPS of $-0.95 on revenue of $12.07M.
Nurix 's are down 59% and is trading at $11.82 , still down 67.38% from its 52 week high of $36.24 set on Wednesday, October 27, 2021.
Nurix follows other major Healthcare sector earnings this month
Nurix's report follows an earnings beat by Merck ADR on Friday, September 9, 2022, who reported EPS of $0.5392 on revenue of $5.69B, EPS of $0.5165 on revenue of $5.57B.
Carl Zeiss Meditec ADR had beat expectations on Friday, September 9, 2022 with third quarter EPS of $0.7134 on revenue of $486.54M, for EPS of $0.7116 on revenue of $486.31M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar